Pain management billing: frequency limits, imaging guidance and diagnostic blocks

This is the most mechanical denial in the specialty and the easiest to eliminate outright. Many interventional spine codes have imaging guidance bundled into the code itself, and billing fluoroscopy separately alongside them triggers an NCCI edit.

The confusion is understandable — fluoroscopy genuinely was separately reportable for some of these procedures historically, and older habits persist in charge templates long after the code descriptors changed.

Payers cap how many injections of a given type they will cover in a period, and the cap is set in published medical policy rather than negotiated per claim. Exceeding it denies, and appealing a straightforward frequency denial rarely succeeds because the payer applied its own stated rule correctly.

Two details cause most of the failures. The period is usually rolling rather than calendar — twelve months back from the date of service, not the current year — so a practice tracking by calendar year will approve a procedure the payer counts as exceeding the limit. And the count often spans levels and sides in ways that are not intuitive, so bilateral or multi-level work can consume the allowance faster than the visit count suggests.

The control is tracking injections per patient against the specific payer's stated limit and period, visible at scheduling rather than discovered at adjudication. Because the limits are published, this is one of the few denial categories that can be reduced to nearly zero with configuration rather than judgement.

Payers approve repeat injections on evidence that the previous one worked. What the record has to establish is specific and quantitative: how much relief the patient obtained, expressed as a percentage, and how long it lasted.

A note recording that the patient “did well” or “had good relief” supports nothing. A note recording “70% reduction in pain sustained for approximately nine weeks, with return of symptoms thereafter” supports the repeat directly, in the terms the policy is written in.

This is the single highest-yield documentation change available in the specialty, because it converts an appeal that fails on vagueness into one that succeeds on the record. It also has to be captured at the follow-up visit — reconstructing a percentage of relief months later, after the denial arrives, is neither accurate nor credible.

Where relief was inadequate, that is also worth documenting plainly. A repeat injection after a failed one is harder to justify, and the clinical decision to proceed anyway should be reasoned in the note rather than left implicit.

Ablation is rarely approved on symptoms alone. Payer policies generally require prior diagnostic medial branch blocks demonstrating that the targeted nerves are in fact the pain source, and the requirement is specific about how many blocks and what response threshold.

The thresholds vary. Many policies require two separate diagnostic blocks, each producing a high percentage of relief — commonly eighty percent or more — over the expected duration of the anesthetic. Others accept a single block or a lower threshold. Because the requirement differs by payer, and by plan within a payer, the only reliable approach is reading the applicable policy before scheduling the ablation rather than after.

The denial this produces is expensive and entirely avoidable. The ablation is performed, the payer asks what diagnostic blocks preceded it, and either the blocks were never done or the record does not quantify the response they produced. The procedure was clinically appropriate and is nonetheless unpayable, because the prerequisite was procedural rather than clinical.

Interventional procedures carry meaningful claim values, and most require authorisation. Authorisation issues are the third-largest denial category industry-wide at 12.8% according to Optum's analysis of 124 million claim remits, and in this specialty they attach to unusually large claims.

The recurring failure is not forgetting authorisation entirely. It is authorisation that does not match what was performed — approved for one level and two were done, approved for a right-side injection and the left was treated, approved for a diagnostic block and an ablation followed, or approved within a date range that expired before the procedure was scheduled.

Optum found that 84% of denials are potentially avoidable and that 22% of those become unrecoverable once they occur. Interventional pain sits at the high end of the avoidable range, because nearly every denial category in the specialty is determined by information available before the procedure.

Frequency limits are published. Medical policies stating diagnostic block requirements are published. Which codes include imaging guidance is in the code descriptor. Authorisation requirements are knowable at scheduling. None of this requires clinical judgement to get right — it requires the information to be in front of the person booking the case.

Premier Inc. puts the average administrative cost of fighting a denied claim at $57.23, and roughly 70% of denials are eventually overturned. Given interventional claim values, appealing is economically sound here and worth doing systematically. But an appeal on a frequency limit correctly applied, or an ablation performed without its prerequisite blocks, is an appeal that was lost before it was written.